COR - Cencora Inc.
Close
239.57
1.970 0.822%
Share volume: 1,229,115
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Drugs and Druggists' Sundries Merchant Wholesalers :
1.32%
PREVIOUS CLOSE
CHG
CHG%
$237.60
1.97
0.83%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-11-22 | 2023-02-01 | 2023-05-02 | 2023-08-02 | 2023-11-21 | 2024-01-31 | 2024-05-01 | 2024-07-31 | |
| Total revenue | 61.174 B | 62.847 B | 63.457 B | 66.947 B | 68.922 B | 72.253 B | 68.414 B | 74.241 B | |
| Cost of revenue | 59.189 B | 60.701 B | 61.162 B | 64.682 B | 66.669 B | 69.784 B | 65.876 B | 71.831 B | |
| Gross profit | 1.986 B | 2.146 B | 2.295 B | 2.265 B | 2.253 B | 2.469 B | 2.538 B | 2.411 B | |
| 8.08% | 6.97% | -1.34% | -0.49% | 9.56% | 2.80% | -5.01% | |||
| Operating expenses | 1.263 B | 1.291 B | 1.321 B | 1.304 B | 1.394 B | 1.399 B | 1.389 B | 1.383 B | |
| Selling general and admin | 1.263 B | 1.291 B | 1.321 B | 1.304 B | 1.394 B | 1.399 B | 1.389 B | 1.383 B | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 60.623 B | 62.164 B | 62.724 B | 66.261 B | 68.339 B | 71.453 B | 67.537 B | 73.486 B | |
| 2.54% | 0.90% | 5.64% | 3.14% | 4.56% | -5.48% | 8.81% | |||
| Operating income | 551.535 M | 683.085 M | 732.889 M | 686.233 M | 583.398 M | 799.462 M | 877.481 M | 754.976 M | |
| Ebit | 551.535 M | 683.085 M | 732.889 M | 686.233 M | 583.398 M | 799.462 M | 877.481 M | 754.976 M | |
| Pretax income | 382.340 M | 593.455 M | 512.130 M | 608.828 M | 446.423 M | 783.398 M | 467.066 M | 628.334 M | |
| 55.22% | -13.70% | 18.88% | -26.68% | 75.48% | -40.38% | 34.53% | |||
| Income tax | 83.664 M | 117.285 M | 83.917 M | 129.615 M | 97.443 M | 180.390 M | 45.861 M | 140.740 M | |
| Net income basic | 294.737 M | 479.745 M | 435.402 M | 479.581 M | 350.565 M | 601.500 M | 420.775 M | 483.463 M | |
| 62.77% | -9.24% | 10.15% | -26.90% | 71.58% | -30.05% | 14.90% | |||
| Net income | 294.737 M | 479.745 M | 435.402 M | 479.581 M | 350.565 M | 601.500 M | 420.775 M | 483.463 M | |
| 62.77% | -9.24% | 10.15% | -26.90% | 71.58% | -30.05% | 14.90% |